Go to Bing homepage

This week was ruled by cancer data presentations by drug companies at the annual meeting of the American Association for Cancer Research (AACR) in Chicago. Other than that, J&J (NYSE:JNJ) and Novartis (NYSE:NVS) kicked off 2018 …

Investors may find my commentary, albeit very high-level and brief, on Merck & Co …

(RTTNews.com) - Merck & Co Inc. ( MRK) announced Monday morning that its Phase 3 study ... Merck gapped up at the open Monday and has continued to rise in early trade. The stock is now up 1.86 at $59.03 and has climbed to over a 2 …

In what's been a wild day for drug stocks, Dynavax Technologies Corporation (NASDAQ:DVAX) shares are climbing, up 4.9% to trade at $20.72, getting a halo …

Commerce Bank acquired 108,321 shares as Merck & Co Inc (MRK)’s stock declined 4.63%. The Commerce Bank …

The markets picked Merck as the winner based on its data. Merck's stock was up …

Procter & Gamble Co.'s stock (PG)sank 2.9% after the consumer-products giant agreed to acquire a consumer-health business from Germany's Merck KGaA (MRK.XE), in a $4.2 billion deal (http://www.marketwatch.com/story/pg-to …

Merck & Co (NYSE:MRK) has potential upside of 17.9% based on a current price of $56.24 and analysts' consensus price target of $66.33. The stock should find initial support at its 50-day moving average (MA) of $53.97 and further support at …

Procter & Gamble Co.'s stock (PG)sank 3.3% after the consumer-products giant agreed to acquire a consumer-health business from Germany's Merck KGaA (MRK.XE), in a $4.2 billion deal (http://www.marketwatch.com/story/pg-to …

Shares of Merck & Co (NYSE:MRK) opened today above their pivot of $53.61 and have ... price of $0.00 and an average consensus analyst price target of $66.33. The stock should run into initial resistance at its 200-day moving average …